Kazuki Horiuchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kazuki Horiuchi has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Tatsuya Natori
Department of Laboratory Medicine, Shinshu University Hospital, Nagano, Japan
5 shared publications- Noriyuki Nagano
Department of Health and Medical Sciences, Shinshu University Graduate School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan; Department of Medical Sciences, Shinshu University Graduate School of Medicine, Science and Technology, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
4 shared publications - Shota Koide
Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan
4 shared publications Tomohiro Denda
Department of Health and Medical Sciences, Shinshu University Graduate School of Medicine, Nagano, Japan
4 shared publicationsYukiko Nagano
Department of Health and Medical Sciences, Shinshu University Graduate School of Medicine, Nagano, Japan
4 shared publications- Mizuki Tanabe
Department of Health and Medical Sciences, Shinshu University Graduate School of Medicine, Nagano, Japan
3 shared publications
Latest Publications
- 8 April 2026
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 41 (2) , e70123
Laser Doppler Flowmetry as a Predictive Tool for Poor Venous Flow in Leukapheresis
Poor venous flow during leukapheresis may compromise cell collection; however, reliable predictors remain limited. We retrospectively analyzed 146 leukapheresis procedures involving patients with hematologic malignancies ( n = 79) and healthy donors ( n = 67) at two institutions, with continuous monitoring of peripheral blood flow using laser Doppler flowmetry (LDF). Poor venous flow, defined in this study as persistent low inlet pressure requiring a > 10% reduction in the draw rate to continue leukapheresis, occurred in 29.1% of patients and 26.9% of donors. In patients, multiple myeloma, lower baseline blood flow, and higher pulse amplitude were independently associated with poor venous flow, whereas in donors, older age was an independent predictor. Peripheral blood flow decreased at the onset of poor venous flow without concomitant changes in blood pressure or LDF‐derived pulse rate. These findings suggest that LDF may help predict poor venous flow during leukapheresis and support pre‐procedural risk stratification.
- 8 April 2026
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 41 (2) , e70123
Laser Doppler Flowmetry as a Predictive Tool for Poor Venous Flow in Leukapheresis
Poor venous flow during leukapheresis may compromise cell collection; however, reliable predictors remain limited. We retrospectively analyzed 146 leukapheresis procedures involving patients with hematologic malignancies ( n = 79) and healthy donors ( n = 67) at two institutions, with continuous monitoring of peripheral blood flow using laser Doppler flowmetry (LDF). Poor venous flow, defined in this study as persistent low inlet pressure requiring a > 10% reduction in the draw rate to continue leukapheresis, occurred in 29.1% of patients and 26.9% of donors. In patients, multiple myeloma, lower baseline blood flow, and higher pulse amplitude were independently associated with poor venous flow, whereas in donors, older age was an independent predictor. Peripheral blood flow decreased at the onset of poor venous flow without concomitant changes in blood pressure or LDF‐derived pulse rate. These findings suggest that LDF may help predict poor venous flow during leukapheresis and support pre‐procedural risk stratification.
- Open Access
- 27 December 2023
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 36, 139-141
Commonality of multispecies GES carbapenemase-producing organisms in hospital wastewater with those in previously investigated epidemiologically linked municipal wastewater influents
- 27 December 2023
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 36, 139-141
Open AccessCommonality of multispecies GES carbapenemase-producing organisms in hospital wastewater with those in previously investigated epidemiologically linked municipal wastewater influents
- Open Access
- 19 December 2023
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 36, 62-64
Comparative analysis of blaNDM-1-carrying plasmids harboured by four different Acinetobacter species from hospital environments and patients during 2018–2022
- 19 December 2023
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 36, 62-64
Open AccessComparative analysis of blaNDM-1-carrying plasmids harboured by four different Acinetobacter species from hospital environments and patients during 2018–2022
- Open Access
- 2 November 2023
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 35, 322-324
A novel blaNDM-1-carrying multidrug-resistant genomic island GIMmSU8481 in a faecal Morganella morganii subsp. sibonii isolate from a patient
- 2 November 2023
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 35, 322-324
Open AccessA novel blaNDM-1-carrying multidrug-resistant genomic island GIMmSU8481 in a faecal Morganella morganii subsp. sibonii isolate from a patient
- Open Access
- 31 July 2023
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 34, 211-213
Novel genomic island carrying a new vanD allele in a vancomycin-resistant Enterococcus faecium clinical isolate belonging to clade A1 in Japan
- 31 July 2023
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 34, 211-213
Open AccessNovel genomic island carrying a new vanD allele in a vancomycin-resistant Enterococcus faecium clinical isolate belonging to clade A1 in Japan
- Open Access
- 20 October 2021
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 70 (10) , 001448
Antibiotic resistance and the presence of bla CfxA and bla CSP genes in β-lactamase-producing clinical Capnocytophaga isolates from a university hospital in Japan
Introduction . Capnocytophaga species are common inhabitants of the oral cavity and can be responsible for systemic diseases in immunocompromised patients with granulocytopenia. Furthermore, it has been reported that some clinical isolates of Capnocytophaga species produce extended-spectrum β-lactamases (ESBLs). Gap statement. Information is lacking about the types of β-lactamase genes possessed by Capnocytophaga spp. and the antimicrobial susceptibility of Capnocytophaga spp. possessing each β-lactamase gene. Aim. The aim of this study was to investigate the presence of β-lactamase genes in clinical strains of β-lactamase-producing Capnocytophaga species isolated from clinical samples acquired at Shinshu University Hospital and examine the antimicrobial susceptibility of those strains. Methodology. The β-lactamase-producing Capnocytophaga species (n=49) were obtained from clinical specimens. PCR assays were used to detect bla CfxA, bla CSP, bla TEM, bla CepA/CblA and transposon Tn4555 genes. Southern hybridization assays were used to detect bla CfxA and bla CSP. The minimum inhibitory concentration of some β-lactams was determined using the E-test method. Results. PCR analysis indicated that the bla CfxA gene was present in 15 (30.6 %) and the bla CSP gene in 35 (69.3 %) of the 49 Capnocytophaga strains investigated, . Both bla CfxA and bla CSP genes were detected in a Capnocytophaga gingivalis strain. The PCR results were confirmed by Southern hybridization assays. Transposon Tn4555 was only detected in Capnocytophaga spp. harbouring the bla CfxA gene. All the β-lactamase-producing Capnocytophaga isolates were susceptible to ceftazidime–clavulanic acid, cefoxitin and imipenem. In contrast, most of the isolates were resistant to amoxicillin. Conclusions. The clinical isolates of Capnocytophaga spp. showed a high prevalence of the bla CSP gene in Japan. The presence of the bla CSP gene was distributed in Capnocytophaga sputigena as well as other Capnocytophaga spp. These results seem to suggest the dissemination of bla CfxA and bla CSP β-lactamase genes among Capnocytophaga species.
- 20 October 2021
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 70 (10) , 001448
Open AccessAntibiotic resistance and the presence of bla CfxA and bla CSP genes in β-lactamase-producing clinical Capnocytophaga isolates from a university hospital in Japan
Introduction . Capnocytophaga species are common inhabitants of the oral cavity and can be responsible for systemic diseases in immunocompromised patients with granulocytopenia. Furthermore, it has been reported that some clinical isolates of Capnocytophaga species produce extended-spectrum β-lactamases (ESBLs). Gap statement. Information is lacking about the types of β-lactamase genes possessed by Capnocytophaga spp. and the antimicrobial susceptibility of Capnocytophaga spp. possessing each β-lactamase gene. Aim. The aim of this study was to investigate the presence of β-lactamase genes in clinical strains of β-lactamase-producing Capnocytophaga species isolated from clinical samples acquired at Shinshu University Hospital and examine the antimicrobial susceptibility of those strains. Methodology. The β-lactamase-producing Capnocytophaga species (n=49) were obtained from clinical specimens. PCR assays were used to detect bla CfxA, bla CSP, bla TEM, bla CepA/CblA and transposon Tn4555 genes. Southern hybridization assays were used to detect bla CfxA and bla CSP. The minimum inhibitory concentration of some β-lactams was determined using the E-test method. Results. PCR analysis indicated that the bla CfxA gene was present in 15 (30.6 %) and the bla CSP gene in 35 (69.3 %) of the 49 Capnocytophaga strains investigated, . Both bla CfxA and bla CSP genes were detected in a Capnocytophaga gingivalis strain. The PCR results were confirmed by Southern hybridization assays. Transposon Tn4555 was only detected in Capnocytophaga spp. harbouring the bla CfxA gene. All the β-lactamase-producing Capnocytophaga isolates were susceptible to ceftazidime–clavulanic acid, cefoxitin and imipenem. In contrast, most of the isolates were resistant to amoxicillin. Conclusions. The clinical isolates of Capnocytophaga spp. showed a high prevalence of the bla CSP gene in Japan. The presence of the bla CSP gene was distributed in Capnocytophaga sputigena as well as other Capnocytophaga spp. These results seem to suggest the dissemination of bla CfxA and bla CSP β-lactamase genes among Capnocytophaga species.